Compare Latin American CDMOs across Brazil, Mexico, Argentina, and beyond. Filter by regulatory approvals, manufacturing type, and regional market access capabilities.
Latin America's pharmaceutical manufacturing is concentrated in Brazil (ANVISA regulation, largest market by volume), Mexico (COFEPRIS regulation, proximity to US market), and Argentina (strong generics and biosimilar expertise). The region is underserved by global CDMOs, creating opportunities for local manufacturers that understand regional regulatory requirements.
Brazil's ANVISA is the most influential regulator in the region, with stringent GMP requirements that approach FDA/EMA standards. Brazilian CDMOs serve a domestic market of 210+ million people and increasingly export to other LATAM countries. Mexico's COFEPRIS provides a fast-growing pharmaceutical market with the additional advantage of proximity to the US for supply chain integration.
Regional market access is the primary value proposition. Many global pharma companies need local manufacturing to meet technology transfer requirements, local content regulations, or to access government procurement programs. CDMOs in Latin America that offer both manufacturing and regulatory support for LATAM registrations provide significant value.
No companies found in this category yet. Check back soon.
Browse all CDMOsOur AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.